Karmayogi Sadhana Saptah brings Ministries, States and Training Institutions Together (See 'Corp Brief') GoI signs Agreement to provide SAMPANN 'platform-as-a-service' to State Government of Goa (See 'Corp Brief') Ministry of Coal reports Record-Breaking Production (See 'Corp Brief') PTC Saharanpur not just an Institution but a Living Legacy of Service: Scindia (See 'Corp Brief') IPR - Failure of party to file opposition to registration of trademark u/s 21 of Trade Marks Act, does not disentitle such genuinely aggrieved party from subsequently seeking revocation, cancellation, or rectification of said trademark: HC (See 'Legal Desk') Geological Survey of India concludes Field Season in Mineral Exploration (See 'Corp Brief') IndiaAI and CDSCO launch Health Innovation Acceleration Hackathon (See 'Corp Brief') West Asia crisis: Customs duty exemption granted to petrochemical products (See 'Corp Brief') PC Act - If other materials on record are creditworthy and reliable, there would be no bar on relying on same for arriving at conclusion regarding guilt of accused: HC (See 'Legal Desk') Chouhan launches landmark Initiative to Unite Policy, Science, and Field Experience on One Platform (See 'Corp Brief') BCGCL and MCL sign Landmark Land Leasing Agreement for Coal to Ammonium Nitrate Project (See 'Corp Brief') IPR - Plaintiff's failure to conclusively establish its exclusive proprietorship over trademarks, coupled with evidence of joint ownership & authorization letter produced by Defendant, meant that matter required full trial: HC (See 'Legal Desk') Railways sets New Record in Passenger Traffic as well as Cargo Transport (See 'Corp Brief') NHAI achieves Robust Growth in NH Development During FY 2025-26 (See 'Corp Brief') PMLA - If specific property was inadvertently omitted in impugned order, case must be remanded back to Adjudicating Authority for limited purpose of passing specific order: SAFEMA (See 'Legal Desk') Nyaya Setu AI Chatbot and Mascot 'DISHIKA' unveiled at DISHA Programme (See 'Corp Brief') Misc - Recipient of concession has no legally enforceable right against Government to grant of concession except to enjoy benefits of concession during period of its grant: SC (See 'Legal Desk') After Signing reformed linked MoU, 5 States got funds under Jal Jeevan Mission 2.0 (See 'Corp Brief') India's largest collaborative Capacity Building Initiative Begins on 2nd April (See 'Corp Brief') IPR - Section 19 of Trade Marks Act, does not permit any third party to make application before Registrar for withdrawal of acceptance of trademark application: HC (See 'Legal Desk') MSME Ministry organizes Entrepreneur Awareness Camp in Dimapur (See 'Corp Brief') Govt and RBI Measures ensure Seamless Rural Credit Flow (See 'Corp Brief') DGCA signs MoU with Gati Shakti Vishwavidyalaya to train youth (See 'Corp Brief') Record 30 Mineral Blocks operationalised in FY 2025-26 (See 'Corp Brief') IPR - No infringement action will lie at instance of one registered proprietor of trade mark against another registered proprietor, seeking injunction against use, by latter, in class in which it is registered: HC (See 'Legal Desk') NCL achieves 140 MT Coal Production Target Ahead of Schedule (See 'Corp Brief') Jan Dhan Darshak App enables GIS-based monitoring of banking infrastructure (See 'Corp Brief') Gati Shakti Vishwavidyalaya & DGCA sign MoU to Revamp Aircraft Maintenance & Create Jobs (See 'Corp Brief') Benami Act - registration of title, payment of stamp duty, deposit of TDS, and routing of payments through banking channels do not negate benami nature of transaction if source of funds originates from another person: SAFEMA (See 'Legal Desk') Goyal meets UK Secretary of State for Business and Trade (See 'Corp Brief') Access Control & AI-Enabled CCTV Systems to streamline Passenger Flow at Railway stations (See 'Corp Brief') IPR - Order passed by Controller of Patents, which lacks independent analysis and is verbatim reproduction of submissions of one party or recommendations of Opposition Board, is procedurally flawed: HC (See 'Legal Desk') Gut Microbiota and Probiotic Science Foundation organises 16th India Probiotic Symposium (See 'Corp Brief') IPR - Overall appearance at first impression is crucial to identify passing off, and meticulous side-by-side dissection is not necessary and trade dress has to be judged as whole: HC (See 'Legal Desk') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

Print

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.